Modern Etiotropic Therapy of Influenza and ARVI in Adult Patients with Premorbid Pathology
An open comparative observational study of the clinical efficacy and safety of riamilovir (Triazavirin™) in patients over age 18 with influenza and acute respiratory viral infections (ARVIs) was conducted during the epidemic seasons of2016-2017 and 2017-2018. Clinical efficacy and safety of riamilov...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2020-05-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/96 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | An open comparative observational study of the clinical efficacy and safety of riamilovir (Triazavirin™) in patients over age 18 with influenza and acute respiratory viral infections (ARVIs) was conducted during the epidemic seasons of2016-2017 and 2017-2018. Clinical efficacy and safety of riamilovir (Triazavirin™) in groups of patients with influenza and ARVI was demonstrated. The use of riamilovir (Triazavirin™) allowed to achieve rapid positive dynamics in the management of febrile-intoxication and catarrhal-respiratory syndromes; it was equally effective in patients who did not immediately seek professional help. |
|---|---|
| ISSN: | 0235-2990 |